7 years of revenue, profit, cash flow and balance-sheet history through FY2026,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 1669.4% per year over the past 5 years.
Financial health
Operating income covered interest expense -3839.8× in the latest year, down from 102× 5 years ago.
The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2026
$17M
-$246M
128.3%
-1381.9%
457.3%
-136.6%
-$21M
—
$6M
2025
$985009
-$14M
1103.3%
-1269.0%
-15.2%
-11.1%
-$9M
—
$3M
2024
—
-$24M
—
—
-363.1%
-100.6%
-$1M
—
$661415
2023
—
-$17M
—
—
-62.8%
-27.4%
-$734887
$28M
$4M
2022
—
-$2M
—
—
-7.1%
-4.2%
-$6M
—
$7M
2021
—
$3M
—
—
14.0%
10.9%
$2M
—
$15M
2020
—
-$5M
—
—
-247.1%
-84.1%
-$6M
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$3M
-$25M
112.1%
-1033.2%
45.6%
-13.6%
-$4M
—
$6M
Mar '26
$4M
-$109M
124.1%
-3045.4%
210.6%
-54.6%
-$5M
—
$3M
Dec '25
—
-$179M
—
—
-367.3%
-66.0%
-$3M
—
$2M
Sep '25
—
$67M
—
—
31.7%
15.9%
-$10M
—
$2M
Jun '25
$985009
-$7M
345.7%
-660.3%
-7.7%
-5.6%
-$4M
—
$3M
Mar '25
$0
-$4M
—
—
-207.0%
-25.4%
-$809299
—
$230392
Dec '24
—
-$1M
—
—
-34.6%
-7.4%
-$1M
—
$406347
Sep '24
—
-$2M
—
—
-32.3%
-8.7%
-$2M
—
$2M
Mar '24
—
-$4M
—
—
-18.7%
-7.3%
$600941
—
$224318
Dec '23
—
-$2M
—
—
-9.6%
-3.9%
$1790
—
$566677
Sep '23
—
-$1M
—
—
-4.9%
-2.1%
-$4M
$27M
$519469
Mar '23
—
-$2M
—
—
-4.8%
-2.4%
-$1M
—
$1M
Dec '22
—
$3M
—
—
7.0%
3.4%
$6M
—
$5M
Sep '22
—
-$3M
—
—
-10.2%
-5.6%
-$3M
—
$3M
Jun '22
—
-$3M
—
—
-8.9%
-5.3%
-$2M
—
$7M
Mar '22
—
-$52667
—
—
-0.2%
-0.2%
$409876
—
$5M
Dec '21
—
$64833
—
—
0.2%
0.2%
-$5M
—
$7M
Sep '21
—
$511711
—
—
2.1%
1.8%
$650488
—
$13M
Jun '21
—
$3M
—
—
12.8%
10.0%
$2M
—
$15M
Mar '21
—
$966763
—
—
26.0%
—
$695118
—
—
Valuation over time
How the market has priced UPXI against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 247.6× (Jun '25) to 3.5× (Nov '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is UPXI growing its revenue and profit?
Over the past 5 years, UPEXI, INC.'s revenue has grown 1669.4% per year. These are computed facts, not advice.
How much debt does UPXI have?
As of FY2026, UPEXI, INC. reported — of total debt against $6M of cash; operating income covered interest expense -3839.8×.
What is UPXI's profit margin?
In FY2026, gross margin was 128.3%, operating margin -1381.9%, and net margin -1411.8%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.